Founded Year
2022Stage
Seed | AliveAbout Neomics Pharmaceuticals
Neomics Pharmaceuticals focuses on the development of adaptive immune cell products for the treatment of various solid tumors. The company was founded in 2022 and is based in Shanghai, China.
Missing: Neomics Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Neomics Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Neomics Pharmaceuticals Patents
Neomics Pharmaceuticals has filed 1 patent.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immune system
- Immunology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/4/2022 | Clusters of differentiation, Transcription factors, Immunology, Immune system, Proteins | Application |
Application Date | 1/4/2022 |
|---|---|
Grant Date | |
Title | |
Related Topics | Clusters of differentiation, Transcription factors, Immunology, Immune system, Proteins |
Status | Application |
Neomics Pharmaceuticals Frequently Asked Questions (FAQ)
When was Neomics Pharmaceuticals founded?
Neomics Pharmaceuticals was founded in 2022.
Where is Neomics Pharmaceuticals's headquarters?
Neomics Pharmaceuticals's headquarters is located at Room 1031, 10th Floor, No. 8 Jiafeng Road, Shanghai.
What is Neomics Pharmaceuticals's latest funding round?
Neomics Pharmaceuticals's latest funding round is Seed.
Who are the investors of Neomics Pharmaceuticals?
Investors of Neomics Pharmaceuticals include Shanghai Biomedical Industry Equity Investment Fund Management.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.